It was generally a steady year in the top pharmaceutical companies, based on full year 2018 pharma sales. There were notable fluctuations, but nothing like what will be in store for the industry if the big deals and M&A that have been announced in 2019 move forward as anticipated. The industry is poised for a major reshaping in the years ahead.
One of the big movers in the Scrip 100 top 10 rankings this year was Bristol-Myers Squibb Co., which...